Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36


[Endoscopic decompression of orbit in Graves' orbitopathy].

Poślednik KB, Miśkiewicz P, Jabłońska-Pawlak A, Kantor I, Szczepański MJ.

Pol Merkur Lekarski. 2019 May 27;46(275):224-228. Review. Polish.


Tympanometric evaluation of Eustachian tube function in Polish scuba divers.

Cyran AM, Kosla A, Kantor I, Szczepanski MJ.

Undersea Hyperb Med. 2018 Jul-Aug;45(4):437-443.


RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy.

Olejarz W, Łacheta D, Głuszko A, Migacz E, Kukwa W, Szczepański MJ, Tomaszewski P, Nowicka G.

Biomed Res Int. 2018 Aug 26;2018:7675286. doi: 10.1155/2018/7675286. eCollection 2018. Review.


Microvessel density in head and neck squamous cell carcinoma.

Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A.

Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1845-1851. doi: 10.1007/s00405-018-4996-2. Epub 2018 May 10.


Internal Carotid Artery Aneurysm Mimicking Peritonsillar Abscess.

Brzost J, Cyran AM, Waniewska M, Szczepanski MJ.

Case Rep Otolaryngol. 2015;2015:389298. doi: 10.1155/2015/389298. Epub 2015 Jun 1.


Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps.

Dzaman K, Szczepanski MJ, Molinska-Glura M, Krzeski A, Zagor M.

Arch Immunol Ther Exp (Warsz). 2015 Jun;63(3):223-30. doi: 10.1007/s00005-014-0325-7. Epub 2014 Dec 12.


Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Szczepanski MJ, Luczak M, Olszewska E, Molinska-Glura M, Zagor M, Krzeski A, Skarzynski H, Misiak J, Dzaman K, Bilusiak M, Kopec T, Leszczynska M, Witmanowski H, Whiteside TL.

J Mol Med (Berl). 2015 Mar;93(3):305-14. doi: 10.1007/s00109-014-1217-3. Epub 2014 Nov 12.


Cancer stem cells in head and neck squamous cell carcinoma.

Szafarowski T, Szczepanski MJ.

Otolaryngol Pol. 2014 May-Jun;68(3):105-11. doi: 10.1016/j.otpol.2013.10.010. Epub 2013 Nov 5.


Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.

Wen Y, Zand B, Ozpolat B, Szczepanski MJ, Lu C, Yuca E, Carroll AR, Alpay N, Bartholomeusz C, Tekedereli I, Kang Y, Rupaimoole R, Pecot CV, Dalton HJ, Hernandez A, Lokshin A, Lutgendorf SK, Liu J, Hittelman WN, Chen WY, Lopez-Berestein G, Szajnik M, Ueno NT, Coleman RL, Sood AK.

Cell Rep. 2014 Apr 24;7(2):488-500. doi: 10.1016/j.celrep.2014.03.009. Epub 2014 Apr 3.


Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?

Szczepanski MJ, Whiteside TL.

Biomark Med. 2013 Aug;7(4):575-8. doi: 10.2217/bmm.13.68. No abstract available.


The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.

Czystowska M, Gooding W, Szczepanski MJ, Lopez-Abaitero A, Ferris RL, Johnson JT, Whiteside TL.

Clin Cancer Res. 2013 Feb 15;19(4):889-99. doi: 10.1158/1078-0432.CCR-12-2191. Epub 2012 Dec 19.


PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.

Szczepanski MJ, DeLeo AB, Łuczak M, Molinska-Glura M, Misiak J, Szarzynska B, Dworacki G, Zagor M, Rozwadowska N, Kurpisz M, Krzeski A, Kruk-Zagajewska A, Kopec T, Banaszewski J, Whiteside TL.

Oral Oncol. 2013 Feb;49(2):144-51. doi: 10.1016/j.oraloncology.2012.08.005. Epub 2012 Sep 1.


17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.

Szajnik M, Szczepanski MJ, Elishaev E, Visus C, Lenzner D, Zabel M, Glura M, DeLeo AB, Whiteside TL.

Gynecol Oncol. 2012 Dec;127(3):587-94. doi: 10.1016/j.ygyno.2012.08.010. Epub 2012 Aug 17.


Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, Brand RE, Ferrone CR, Whiteside TL, Ferrone S, DeLeo AB, Wang X.

Clin Cancer Res. 2011 Oct 1;17(19):6174-84. doi: 10.1158/1078-0432.CCR-11-1111. Epub 2011 Aug 19.


Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.

Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL, Boyiadzis M.

Haematologica. 2011 Sep;96(9):1302-9. doi: 10.3324/haematol.2010.039743. Epub 2011 May 23.


Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.

Visus C, Ito D, Dhir R, Szczepanski MJ, Chang YJ, Latimer JJ, Grant SG, DeLeo AB.

Cancer Immunol Immunother. 2011 Jul;60(7):919-29. doi: 10.1007/s00262-011-1001-y. Epub 2011 Mar 16.


Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.

Czystowska M, Szczepanski MJ, Szajnik M, Quadrini K, Brandwein H, Hadden JW, Whiteside TL.

Cancer Immunol Immunother. 2011 Apr;60(4):495-506. doi: 10.1007/s00262-010-0951-9. Epub 2010 Dec 23.


Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL.

PLoS One. 2010 Jul 22;5(7):e11469. doi: 10.1371/journal.pone.0011469.


Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.

Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Jackson EK, Johnson JT, Gorelik E, Lang S, Whiteside TL.

J Biol Chem. 2010 Sep 3;285(36):27571-80. doi: 10.1074/jbc.M110.127100. Epub 2010 Jun 17.


c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.

Song JJ, Szczepanski MJ, Kim SY, Kim JH, An JY, Kwon YT, Alcala MA Jr, Bartlett DL, Lee YJ.

Cell Signal. 2010 Mar;22(3):553-63. doi: 10.1016/j.cellsig.2009.11.012.


Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.

Mandapathil M, Hilldorfer B, Szczepanski MJ, Czystowska M, Szajnik M, Ren J, Lang S, Jackson EK, Gorelik E, Whiteside TL.

J Biol Chem. 2010 Mar 5;285(10):7176-86. doi: 10.1074/jbc.M109.047423. Epub 2009 Oct 26.


Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.

Ge L, Baskic D, Basse P, Vujanovic L, Unlu S, Yoneyama T, Vujanovic A, Han J, Bankovic D, Szczepanski MJ, Hunt JL, Herberman RB, Gollin SM, Ferris RL, Whiteside TL, Myers EN, Vujanovic NL.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2913-22. doi: 10.1158/1055-9965.EPI-08-0898. Epub 2009 Oct 20.


TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.

Szajnik M, Szczepanski MJ, Czystowska M, Elishaev E, Mandapathil M, Nowak-Markwitz E, Spaczynski M, Whiteside TL.

Oncogene. 2009 Dec 10;28(49):4353-63. doi: 10.1038/onc.2009.289.


Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.

Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Lenzner DE, Jackson EK, Gorelik E, Lang S, Johnson JT, Whiteside TL.

Clin Cancer Res. 2009 Oct 15;15(20):6348-57. doi: 10.1158/1078-0432.CCR-09-1143. Epub 2009 Oct 13.


Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes.

Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL.

J Immunol. 2009 Sep 15;183(6):3720-30. doi: 10.4049/jimmunol.0900970. Epub 2009 Aug 19.


Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.

Szczepanski MJ, Szajnik M, Welsh A, Foon KA, Whiteside TL, Boyiadzis M.

Cancer Immunol Immunother. 2010 Jan;59(1):73-9. doi: 10.1007/s00262-009-0724-5. Epub 2009 Jun 13.


Biological significance of prolactin in gynecologic cancers.

Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE.

Cancer Res. 2009 Jun 15;69(12):5226-33. doi: 10.1158/0008-5472.CAN-08-4652. Epub 2009 Jun 2.


Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.

Szczepanski MJ, Szajnik M, Czystowska M, Mandapathil M, Strauss L, Welsh A, Foon KA, Whiteside TL, Boyiadzis M.

Clin Cancer Res. 2009 May 15;15(10):3325-32. doi: 10.1158/1078-0432.CCR-08-3010. Epub 2009 May 5.


Role of eotaxin-1 signaling in ovarian cancer.

Levina V, Nolen BM, Marrangoni AM, Cheng P, Marks JR, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE.

Clin Cancer Res. 2009 Apr 15;15(8):2647-56. doi: 10.1158/1078-0432.CCR-08-2024. Epub 2009 Apr 7.


Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A, Szyfter W, Zeromski J, Whiteside TL.

Cancer Res. 2009 Apr 1;69(7):3105-13. doi: 10.1158/0008-5472.CAN-08-3838. Epub 2009 Mar 24.


Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.

Lee DH, Szczepanski MJ, Lee YJ.

J Cell Biochem. 2009 Apr 15;106(6):1113-22. doi: 10.1002/jcb.22098.


IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.

Czystowska M, Han J, Szczepanski MJ, Szajnik M, Quadrini K, Brandwein H, Hadden JW, Signorelli K, Whiteside TL.

Cell Death Differ. 2009 May;16(5):708-18. doi: 10.1038/cdd.2008.197. Epub 2009 Jan 30.


T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.

Bergmann C, Strauss L, Wang Y, Szczepanski MJ, Lang S, Johnson JT, Whiteside TL.

Clin Cancer Res. 2008 Jun 15;14(12):3706-15. doi: 10.1158/1078-0432.CCR-07-5126.


[Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues].

Szajnik M, Nowak-Markwitz E, Szczepański MJ, Spaczyński M.

Ginekol Pol. 2007 Dec;78(12):939-43. Polish.


Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.

Strauss L, Bergmann C, Szczepanski MJ, Lang S, Kirkwood JM, Whiteside TL.

J Immunol. 2008 Mar 1;180(5):2967-80.


Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.

Boyiadzis M, Memon S, Carson J, Allen K, Szczepanski MJ, Vance BA, Dean R, Bishop MR, Gress RE, Hakim FT.

Biol Blood Marrow Transplant. 2008 Mar;14(3):290-300. doi: 10.1016/j.bbmt.2007.12.490.

Supplemental Content

Loading ...
Support Center